nach oben

BMC Surgery

Erschienen in:

Open Access 01.12.2023 | Research

Effects of preoperative bicarbonate and lactate levels on short-term outcomes and prognosis in elderly patients with colorectal cancer

verfasst von: Xiao-Yu Liu, Zi-Wei Li, Bin Zhang, Fei Liu, Wei Zhang, Dong Peng

Erschienen in: BMC Surgery | Ausgabe 1/2023

Abstract

Purpose

The aim of this study was to analyze the effect of preoperative bicarbonate and lactate levels (LL) on the short-term outcomes and prognosis in elderly (≥ 65 years) patients with colorectal cancer (CRC).

Methods

We collected the information of CRC patients from Jan 2011 to Jan 2020 in a single clinical center. According to the results of preoperative blood gas analysis, we divided patients into the higher/lower bicarbonate group and the higher/lower lactate group, and compared their baseline information, surgery-related information, overall survival (OS) and disease-free survival (DFS).

Results

A total of 1473 patients were included in this study. Comparing the clinical data of the higher/lower bicarbonate group and the higher/lower lactate group, the lower group were older (p < 0.01), had higher rates of coronary heart disease (CHD) (p = 0.025), a higher proportion of colon tumors (p < 0.01), larger tumor size (p < 0.01), higher rates of open surgery (p < 0.01), more intraoperative blood loss (p < 0.01), higher overall complications (p < 0.01) and 30-day deaths (p < 0.01). The higher LL patients had more male patients (p < 0.01), higher body mass index (BMI) (p < 0.01) and drinking rates (p = 0.049), higher rates of type 2 diabetes mellitus (T2DM) (p < 0.01) and lower rates of open surgery (p < 0.01). In multivariate analysis, age (p < 0.01), BMI (p = 0.036), T2DM (p = 0.023), and surgical methods (p < 0.01) were independent risk factors of overall complications. The independent risk factors for OS included age (p < 0.01), tumor site (p = 0.014), tumor stage (p < 0.01), tumor size (p = 0.036), LL (p < 0.01), and overall complications (p < 0.01). The independent risk factors of DFS included age (p = 0.012), tumor site (p = 0.019), tumor stage (p < 0.01), LL (p < 0.01), and overall complications (p < 0.01).

Conclusion

Preoperative LL significantly affected postoperative OS and DFS of CRC patients, but bicarbonate might not affect the prognosis of CRC patients. Therefore, surgeons should actively focus on and adjust the LL of patients before surgery.

Additional File 1: Complications between higher bicarbonate and lower bicarbonate.

Additional File 2: Complications between higher lactate and lower lactate.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12893-023-02039-x.

Xiao-Yu Liu and Zi-Wei Li contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

According to Global Cancer Statistics 2020, the global incidence of colorectal cancer (CRC) was increased year by year, and it has now become the second leading cause of cancer-related death after lung cancer and the third leading cause of mortality worldwide. [1‐3] The incidence of CRC is 38.7 per 100,000 and the mortality rate is 13.9 per 100,000 [4]. The treatment methods for CRC including surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy [5, 6]. Radical resection was still the standard treatment for CRC [7, 8]. Elderly patients usually had poor physical function and more comorbidities [9]. Despite tremendous advances in surgical techniques and perioperative management, postoperative morbidity and mortality of elderly patients remained significantly higher after major abdominal surgery [10].

The number of people reaching old age increased rapidly globally according to the United Nations World Population Prospects, people aged 65 and over now accounted for more than 20% of the world’s population [9]. As the average survival age increased, the number of elderly CRC patients undergoing surgery would also continue to increase. Studies have shown that age was an independent risk factor for the occurrence of CRC and for postoperative complications and mortality. [11‐14].

The study of postoperative short-term outcomes and prognostic risk factors in elderly CRC patients has been a hot topic. Studies have reported that preoperative CA19-9 level, ASA grade, low prognostic nutritional index and malnutrition were related to the prognosis of elderly CRC patients. [15‐17] Bicarbonate and lactate levels (LL) were important components of blood gas analysis. However, there was no clear study on whether preoperative bicarbonate and LL affected the prognosis of elderly CRC patients. Therefore, the aim of this study was to analyze the effect of preoperative bicarbonate and LL on short-term outcomes and prognosis in elderly (≥ 65 years) patients with CRC.

Methods

Patients

We collected the information of CRC patients from Jan 2011 to Jan 2020 in a single clinical center. The study was approved by the ethics committee of our institution (The First Affiliated Hospital of Chongqing Medical University, 2022-K205), and all patients signed informed consent forms. This study was conducted in accordance with the World Medical Association Declaration of Helsinki as well.

Inclusion and exclusion criteria

We included the patients who underwent radical CRC surgery (n = 5473). The exclusion criteria were as follows: 1, Stage IV CRC patients (n = 341); 2, Non-R0 CRC surgery (n = 25); 3, Younger (age < 65 years old) CRC patients (n = 2166); 4, Incomplete clinical data (n = 323); and 5, Incomplete information of blood gas analysis (n = 1145). Finally, a total of 1473 CRC patients were included in this study. (Fig. 1)

Clinical data

Clinical data mainly included baseline information and surgery-related data. Baseline information included age, sex, body mass index (BMI), smoking history, drinking history, concomitant disease, tumor location, tumor stage and tumor size. The concomitant diseases mainly included hypertension, type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD). Surgery-related information included surgical method, operative time, blood loss, postoperative hospital stays, retrieved lymph nodes, and postoperative complications. Clinical data were mainly collected through electronic medical record systems.

Follow-up data

The mean follow-up time was 33 (1-114) months. We routinely followed up by telephone for the first time within 1 month after surgery, then every 3 months for 3 years, and every 6 months thereafter. Follow-up data were obtained primarily through telephone interviews and the outpatient care system.

Definitions

This study used the X-tile software (version 3.6.1) to determine the optimal cut-off values for bicarbonate and LL [18]. The best cut-off value for bicarbonate was 25.7mmol/L, and the best cut-off value for lactic acid was 0.9mmol/L. Therefore, we defined bicarbonate ≤ 25.7 as the lower group, and > 25.7 as the higher group; lactic acid ≤ 0.9 as the lower group, and > 0.9 as the higher group. Tumor staging was performed according to the TNM in AJCC 8th Edition [19]. The severity of postoperative complications (POCs) was defined according to the Clavien-Dindo classification [20, 21], where Clavien-Dindo ≥ III was defined as major complications. Overall survival (OS) was defined as the time from surgery to the all-cause death or last follow-up in an individual patient, and disease-free survival (DFS) was defined as the time from surgery to radiographic or pathological confirmation of recurrence, death, or the date of the last follow-up.

Statistical analysis

Continuous variables were expressed as mean ± SD, and frequency variables were expressed as n (%). The above clinical variables were analyzed using independent samples t-test, Fisher’s exact test and Chi-square test by SPSS software (version 22.0). Univariate logistic regression analysis was also performed to find potential predictors of complications, COX regression analysis was performed to identify their independent predictors of OS and DFS. Two-sided P-values less than 0.05 were considered statistically significant.

Results

Patient

A total of 1473 patients were included in this study through the inclusion and exclusion criteria. We divided patients into the higher bicarbonate group (916 patients) and the lower bicarbonate group (557 patients) according to the best cut-off value for bicarbonate of 25.7. According to the best cut-off value for LL of 0.9, we divided patients into the higher lactate group (1315 patients) and the lower lactate group (158 patients). We systematically collected the baseline information, surgery-related information and related information of all patients, as shown in Tables 1 and 2.

Table 1

Comparison between higher bicarbonate and lower bicarbonate

Characteristics	Higher bicarbonate (916)	Lower bicarbonate (557)	P value
Age, year	72.7 ± 5.8	74.0 ± 6.4	< 0.01*
Sex			0.111
Male Female	563 (61.5%) 353 (38.5%)	319 (57.3%) 238 (42.7%)
BMI, kg/m²	22.4 ± 3.2	22.7 ± 3.4	0.076
Smoking	329 (35.9%)	209 (37.5%)	0.535
Drinking	268 (29.3%)	167 (30.0%)	0.768
Hypertension	334 (36.5%)	220 (39.5%)	0.244
T2DM	160 (17.5%)	99 (17.8%)	0.881
CHD	69 (7.5%)	61 (11.0%)	0.025*
Open surgery	75 (8.2%)	104 (18.7%)	< 0.01*
Tumor location			< 0.01*
Colon	411 (44.9%)	343 (61.6%)
Rectum	505 (55.1%)	214 (38.4%)
TNM stage			0.508
I	158 (17.2%)	88 (15.8%)
II	397 (43.3%)	231 (41.5%)
III	319 (34.8%)	205 (36.8%)
IV	42 (4.7%)	33 (5.9%)
Tumor size			< 0.01*
< 5 cm	552 (60.3%)	282 (50.6%)
≥ 5 cm	364 (39.7%)	275 (49.4%)
Operation time (min)	216.3 ± 80.0	221.2 ± 85.9	0.260
Blood loss (mL)	84.3 ± 123.6	103.0 ± 140.5	< 0.01*
Hospital stay (day)	10.8 ± 9.4	11.4 ± 7.7	0.184
Retrieved lymph nodes	15.5 ± 8.0	15.1 ± 6.4	0.260
Overall complications	206 (22.5%)	160 (28.7%)	< 0.01*
Major complications	23 (2.5%)	22 (3.9%)	0.120
30-day deaths	0 (0.0%)	7 (1.3%)	< 0.01*

Note: Variables are expressed as the mean ± SD, n (%), *P-value < 0.05

Abbreviations: T2DM, type 2 diabetes mellitus; BMI, body mass index; CHD, coronary heart disease

Comparison between the higher group and the lower group

In the baseline information, lower bicarbonate patients were older (p < 0.01), had higher rates of CHD (p = 0.025), a higher proportion of colon tumors (p < 0.01) and larger tumor size (p < 0.01); In the surgery-related data, lower bicarbonate patients had higher rates of open surgery (p < 0.01), more intraoperative blood loss (p < 0.01), higher overall complications (p < 0.01) and 30-day deaths (p < 0.01). We found that there was no statistically significant difference in major complications between the high bicarbonate and low bicarbonate group (P = 0.120). (Table 1)

We found that higher lactate patients had more male patients (p < 0.01), higher BMI (p < 0.01) and drinking rates (p = 0.049), higher rates of T2DM (p < 0.01) and lower rates of open surgery (p < 0.01). We found that there was no statistically significant difference in major complications between the high lactate and low lactate group (P = 0.137). (Table 2)

Table 2

Comparison between higher lactate and lower lactate

Characteristics	Higher lactate (1315)	Lower lactate (158)	P value
Age, year	73.2 ± 6.1	73.0 ± 6.0	0.575
Sex			< 0.01*
Male Female	806 (61.3%) 509 (38.7%)	76 (48.1%) 82 (51.9%)
BMI, kg/m²	22.6 ± 3.3	21.5 ± 3.2	< 0.01*
Smoking	487 (37.0%)	51 (32.3%)	0.241
Drinking	399 (30.3%)	36 (22.8%)	0.049*
Hypertension	495 (37.6%)	59 (37.3%)	0.941
T2DM	243 (18.5%)	16 (10.1%)	< 0.01*
CHD	119 (9.0%)	11 (7.0%)	0.382
Open surgery	147 (11.2%)	32 (20.3%)	< 0.01*
Tumor location			0.302
Colon	667 (50.7%)	87 (55.1%)
Rectum	648 (49.3%)	71 (44.9%)
TNM stage			0.807
I	222 (16.9%)	24 (15.2%)
II	555 (42.2%)	73 (46.2%)
III	471 (35.8%)	53 (33.5%)
IV	67 (5.1%)	8 (5.1%)
Tumor size			0.346
< 5 cm	739 (56.2%)	95 (60.1%)
≥ 5 cm	576 (43.8%)	63 (39.9%)
Operation time (min)	218.0 ± 78.7	219.7 ± 108.0	0.798
Blood loss (mL)	90.7 ± 130.4	96.5 ± 131.5	0.601
Hospital stay (day)	10.9 ± 8.2	12.3 ± 12.5	0.054
Retrieved lymph nodes	15.4 ± 7.6	15.4 ± 6.7	0.970
Overall complications	317 (24.1%)	49 (31.0%)	0.058
Major complications	37 (2.8%)	8 (5.1%)	0.137
30-day deaths	7 (0.5%)	0 (0.0%)	1.000

Note: Variables are expressed as the mean ± SD, n (%), *P-value < 0.05

Abbreviations: T2DM, type 2 diabetes mellitus; BMI, body mass index; CHD, coronary heart disease

Univariate and multivariate analysis

We performed multivariate logistic regression analyses and COX regression to identify their independent predictors for complications, OS, DFS. Through analysis, we found that bicarbonate was an influencing factor for overall complications, OS, and DFS, but not an independent risk factor.

Using multivariate logistic regression analysis of overall complications, we found that age (p < 0.01, OR = 1.027, 95% CI = 1.007–1.047), BMI (p = 0.036, OR = 0.961, 95% CI = 0.925–0.997), T2DM (p = 0.023, OR = 1.429, 95% CI = 1.050–1.944), and surgical methods (p < 0.01, OR = 2.124, 95% CI = 1.518–2.970) were independent risk factors. (Table 3)

Table 3

Univariate and multivariate logistic regression analysis of the overall complications

Risk factors	Univariate analysis		Multivariate analysis
Risk factors	OR (95% CI)	P value	OR (95% CI)	P value
Age, year	1.035 (1.016–1.055)	< 0.01*	1.027 (1.007–1.047)	< 0.01*
Sex (male/female)	0.972 (0.764–1.238)	0.820
BMI, Kg/m²	0.957 (0.922–0.992)	0.018*	0.961 (0.925–0.997)	0.036*
Hypertension (yes/no)	1.086 (0.852–1.384)	0.506
T2DM (yes/no)	1.450 (1.080–1.948)	0.014*	1.429 (1.050–1.944)	0.023*
Tumor location (colon/ rectum)	0.981 (0.774–1.242)	0.871
Tumor stage (IV/III/II/I)	1.183 (1.020–1.372)	0.026*	1.110 (0.953–1.294)	0.179
Smoking (yes/no)	1.053 (0.825–1.345)	0.677
Drinking (yes/no)	0.914 (0.704–1.188)	0.502
CHD (yes/no)	1.086 (0.852–1.384)	0.506
Tumor size (≥ 5/ <5), cm	1.251 (0.987–1.586)	0.064
Surgical methods (open/laparoscopic)	2.486 (1.797–3.438)	< 0.01*	2.124 (1.518–2.970)	< 0.01*
Bicarbonate (higher/lower)	0.720 (0.566–0.915)	< 0.01*	0.805 (0.627–1.033)	0.089
Lactate (higher/lower)	0.707 (0.493–1.013)	0.059

Note: *P-value < 0.05

Abbreviations: OR, Odds ratio; CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease

Independent risk factors for OS included age (p < 0.01, HR = 1.033, 95% CI = 1.013–1.054), tumor site (p = 0.014, HR = 1.403, 95% CI = 1.069–1.840), tumor stage (p < 0.01, HR = 2.202, 95% CI = 1.848–2.625), tumor size (p = 0.036, HR = 1.327, 95% CI = 1.018–1.730), LL (p < 0.01, HR = 1.981, 95% CI = 1.230–3.191), and overall complications (p < 0.01, HR = 1.656, 95% CI = 1.266–2.167). (Table 4)

Table 4

Univariate and multivariate analysis of overall survival

Risk factors	Univariate analysis		Multivariate analysis
Risk factors	HR (95% CI)	P value	HR (95% CI)	P value
Age (years)	1.042 (1.021–1.063)	< 0.01*	1.033 (1.013–1.054)	< 0.01*
Sex (female/male)	0.861 (0.730–1.015)	0.074
BMI (kg/m²)	0.974 (0.936–1.013)	0.192
T2DM (yes/no)	1.090 (0.775–1.534)	0.619
Tumor site (colon/ rectum)	1.510 (1.162–1.963)	< 0.01*	1.403 (1.069–1.840)	0.014*
Tumor stage (IV/III/II/I)	2.250 (1.896–2.671)	< 0.01*	2.202 (1.848–2.625)	< 0.01*
Smoking (yes/no)	1.061 (0.813–1.385)	0.662
Drinking (yes/no)	0.971 (0.728–1.295)	0.840
Hypertension (yes/no)	0.837 (0.637–1.099)	0.201
CHD (yes/no)	0.969 (0.939–1.957)	0.890
Tumor size (≥ 5 cm/<5 cm)	1.690 (1.303–2.192)	< 0.01*	1.327 (1.018–1.730)	0.036*
Bicarbonate (higher/lower)	0.636 (0.491–0.823)	< 0.01*	0.769 (0.590–1.002)	0.052
Lactate (higher/lower)	1.818 (1.136–2.911)	0.013*	1.981 (1.230–3.191)	< 0.01*
Overall complications (yes/no)	1.804 (1.383–2.352)	< 0.01*	1.656 (1.266–2.167)	< 0.01*

Note: *P-value < 0.05

Abbreviations: HR, hazard ratio; CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease

As for DFS, the independent risk factors included age (p = 0.012, HR = 1.024, 95% CI = 1.005–1.042), tumor site (p = 0.019, HR = 1.341, 95% CI = 1.050–1.712), tumor stage (p < 0.01, HR = 2.094, 95% CI = 1.788–2.452), LL (p < 0.01, HR = 2.020, 95% CI = 1.230–3.191), and overall complications (p < 0.01, HR = 1.484, 95% CI = 1.158–1.902). (Table 5)

Table 5

Univariate and multivariate analysis of disease-free survival

Risk factors	Univariate analysis		Multivariate analysis
Risk factors	HR (95% CI)	P value	HR (95% CI)	P value
Age (years)	1.032 (1.013–1.051)	< 0.01*	1.024 (1.005–1.042)	0.012*
Sex (female/male)	0.876 (0.689–1.113)	0.277
BMI (kg/m²)	0.979 (0.945–1.014)	0.243
T2DM (yes/no)	0.997 (0.727–1.368)	0.986
Tumor site (colon/ rectum)	1.402 (1.107–1.775)	< 0.01*	1.341 (1.050–1.712)	0.019*
Tumor stage (IV/III/II/I)	2.129 (1.825–2.485)	< 0.01*	2.094 (1.788–2.452)	< 0.01*
Smoking (yes/no)	1.050 (0.825–1.338)	0.691
Drinking (yes/no)	0.968 (0.746–1.257)	0.809
Hypertension (yes/no)	0.867 (0.678–1.108)	0.253
CHD (yes/no)	1.001 (0.669–1.499)	0.995
Tumor size (≥ 5 cm/<5 cm)	1.506 (1.192–1.903)	< 0.01*	1.206 (0.950–1.531)	0.125
Bicarbonate (higher/lower)	0.723 (0.572–0.914)	< 0.01*	0.859 (0.676–1.092)	0.215
Lactate (higher/lower)	1.886 (1.219–2.919)	< 0.01*	2.020 (1.230–3.191)	< 0.01*
Overall complications (yes/no)	1.584 (1.240–2.024)	< 0.01*	1.484 (1.158–1.902)	< 0.01*

Note: *P-value < 0.05

Abbreviations: HR, hazard ratio; CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease

Complications between the higher group and the lower group

By comparing the complications between higher bicarbonate and lower bicarbonate, we found that lower lactate patients had more overall complications (p < 0.01) and more 30-day deaths (p < 0.01). (Table S1)

As for the higher lactate group and the lower lactate group, we found that higher lactate patients had more re-operation patients (p = 0.035). (Table S2)

Discussion

A total of 1473 patients were included in this study. Based on the optimal cutoff values for bicarbonate and LL, we divided patients into higher bicarbonate group (916 patients) and lower bicarbonate group (557 patients), higher lactate group (1315 patients) and lower lactate group (158 patients), respectively. The comparison found that the higher lactate group had more male patients, higher BMI and smoking rate, and higher proportion of preoperative diabetes patients.

LL was a valuable prognostic marker in critically ill patients and their dynamics were strongly associated with mortality in surgical patients. [22‐24] Under normal physiological conditions, lactate was produced by mitochondria-deficient muscles, skin, brain, gut, and red blood cells at approximately 1500 mmol per day. The metabolism of lactate was mainly carried out in the liver (about 60%), kidneys (about 30%) and other organs [25]. The normal lactate concentration was 1 ± 0.5 mmol/l [26, 27]. Under pathological conditions, other organs such as cardiac muscle, skeletal muscle, lung, white blood cells and splanchnic circulation would produce a large amount of lactic acid, thereby increasing the lactic acid concentration [28, 29]. Multiple previous studies have confirmed the impact of LL on surgery: Hajjar LA et al. found that higher lactate was an independent risk factor for cardiac surgery outcomes, [30] O’Connor E et al. found that LL was associated with longer intensive care unit (ICU) length of stay, [29] and Li SH et al. found that initial serum lactate levels was significantly associated with postoperative complications and independently predicted in-hospital morbidity after major abdominal surgery [31].

Through logistic regression analysis or COX regression analysis of overall complications, OS and DFS, we found that preoperative LL was an independent risk factor for OS and DFS, while bicarbonate had little effect on the prognosis of CRC patients. Acidic extracellular pH was a characteristic of the tumor microenvironment. Bicarbonate neutralized the acidic environment by producing CO₂. The reduction of bicarbonate might make the microenvironment acidic. The SLC4 protein family was a bicarbonate transporter protein, and the SLC4A4 was a well-characterized acid-extruders [32]. The acid microenvironment caused by bicarbonate reduction also increased the expression of SLC4A4 in colon cancer cell lines [33]. In addition, the acidic tumor microenvironment promoted the degradation of extracellular matrix, further promoted invasion and metastasis, thereby affecting the prognosis of tumor patients [34].

Under hypoxic conditions, mitochondrial conversion of pyruvate was not possible, and thus, lactate was the end product of anaerobic glycolysis [23]. Elevated lactate was often attributed to two main mechanisms: insufficient oxygen levels (e.g., perfusion defects) and lack of anaerobic glycolysis (e.g., altered clearance, drugs, or malignancy). In other words, elevated serum LL was the product of some combination of overproduction and reduced clearance [35, 36].

High lactate concentrations in tumor biopsies were associated with metastasis and poor clinical outcomes. Tumor evolution was influenced by events involving tumor cells and their living environment, termed the tumor microenvironment (TME) [37, 38]. Cancer cells produce excess lactate through anaerobic glycolysis, even in the presence of an adequate oxygen supply, and large amounts of lactate trigger acidification of the TME, leading to immunosuppressive TME, immune escape in the TME, and tumor-associated macrophages formation of cellular (TAM) dysfunction [34, 39‐41]. Gu J et al. found that lactate enhanced Treg cell stability and function, while lactate degradation reduced Treg cell induction, increased antitumor immunity, and reduced tumor growth [42]. Therefore, patients in the lower lactate group tend to have a better prognosis.

There was no clear study on whether bicarbonate and LL affected the surgical prognosis of elderly CRC patients, so this study was the first study concerning this topic. However, this study also had certain limitations. First, this study only involved one research center and was a retrospective one; second, the follow-up time of this study was short; finally, the subjects of this study were elderly patients aged ≥ 65 years, with a wide age span. Therefore, a multicenter prospective randomized controlled trial with more detailed groupings should be carried out in the future.

In conclusion, preoperative LL significantly affected postoperative OS and DFS of CRC patients, but bicarbonate might not affect the prognosis of CRC patients. Therefore, surgeons should actively focus on and adjust the LL of patients before surgery.

Acknowledgements

We acknowledge all the authors whose publications are referred in our article.

Declarations

Ethics approval and informed consent

The study was approved by the ethics committee of our institution (The First Affiliated Hospital of Chongqing Medical University, 2022-K205), and all patients signed informed consent. This study was conducted in accordance with the World Medical Association Declaration of Helsinki as well.

Not Applicable.

Competing interests

The authors declare no conflicts of interest.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Additional File 1: Complications between higher bicarbonate and lower bicarbonate.

Additional File 2: Complications between higher lactate and lower lactate.

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–49. https://doi.org/10.3322/caac.21660

Liu XY, Kang B, Cheng YX et al. Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer. BMC Cancer 2022 Jun 1; 22 (1): 596. https://doi.org/10.1186/s12885-022-09691-1

Cheng YX, Tao W, Liu XY et al. Hypertension remission after colorectal Cancer surgery: a Single-Center Retrospective Study. Nutr Cancer 2022 Jan 7: 1–7. https://doi.org/10.1080/01635581.2021.2025256

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020 May;70(3):145–64. https://doi.org/10.3322/caac.21601

Weiser MR. AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol. 2018 Jun;25(6):1454–5. https://doi.org/10.1245/s10434-018-6462-1

Liu XY, Yuan C, Kang B, et al. Predictors associated with planned and unplanned admission to intensive care units after colorectal cancer surgery: a retrospective study. Support Care Cancer. 2022 Jun;30(6):5099–105. https://doi.org/10.1007/s00520-022-06939-1

Wang S, Wang X, Zhou T et al. Effectiveness and safety of chinese herbal injections combined with fluoropyrimidine and oxaliplatin-based Chemotherapy for Advanced Colorectal Cancer: a systematic review and Meta-analysis of 63 randomized controlled trials. J Cancer 2021 Oct 25; 12(23): 7237–54. https://doi.org/10.7150/jca.60895

Ogata T, Yoshida N, Sadakari Y et al. Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups. J Gastrointest Oncol 2022 Feb; 13(1): 137–48. https://doi.org/10.21037/jgo-21-627

Koh W, Lee CS, Bae JH et al. Clinical validation of implementing enhanced recovery after surgery protocol in Elderly Colorectal Cancer Patients. Ann Coloproctol 2021 Jul 21; 38(1): 47–52. https://doi.org/10.3393/ac.2021.00283.0040

10.

Liu XY, Li ZW, Kang B, et al. Does Preoperative Waiting Time affect the short-term outcomes and prognosis of Colorectal Cancer Patients? A retrospective study from the West of China. Can J Gastroenterol Hepatol 2022 Apr. 2022;30:8235736. https://doi.org/10.1155/2022/8235736CrossRef

11.

Day LW, Velayos F. Colorectal cancer screening and surveillance in the elderly: updates and controversies. Gut Liver. 2015 Mar;9(2):143–51. https://doi.org/10.5009/gnl14302

12.

Liu XY, Kang B, Cheng YX et al. The short-term and oncologic outcomes of younger VS older colorectal cancer patients undergoing primary surgery: a propensity score matching analysis. BMC Cancer 2022 Feb 8; 22(1): 153. https://doi.org/10.1186/s12885-022-09246-4

13.

Nakayama Y, Kobayashi H, Kawamura H et al. The long-term outcomes in adolescent and young adult patients with colorectal cancer -A multicenter large-scale cohort study. J Cancer 2020 Mar 4; 11(11): 3180–5. https://doi.org/10.7150/jca.36721

14.

Angenete E. Reducing morbidity and mortality in the elderly population with colorectal cancer. Colorectal Dis 2020 Apr; 22(4): 362–3. https://doi.org/10.1111/codi.15029

15.

Shang W, Yuan W, Liu R et al. Factors contributing to the mortality of elderly patients with colorectal cancer within a year after surgery. J Cancer Res Ther 2022 Apr; 18(2): 503–8. https://doi.org/10.4103/jcrt.jcrt_1478_21

16.

17.

Martínez-Escribano C, Arteaga Moreno F, Pérez-López M et al. Malnutrition and increased risk of adverse outcomes in Elderly Patients undergoing elective colorectal Cancer surgery: a case-control study nested in a cohort. Nutrients 2022 Jan 3; 14(1): 207. https://doi.org/10.3390/nu14010207

18.

Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004 Nov 1; 10(21): 7252–9. https://doi.org/10.1158/1078-0432

19.

Weiser MR. AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol. 2018 Jun;25(6):1454–5. https://doi.org/10.1245/s10434-018-6462-1. Epub 2018 Apr 3.

20.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae

21.

Clavien PA, Barkun J, de Oliveira ML et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009 Aug; 250(2): 187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2

22.

Vincent JL, Quintairos E, Silva A, Couto L Jr et al. The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care 2016 Aug 13; 20(1): 257. https://doi.org/10.1186/s13054-016-1403-5

23.

Tonello M, Barina A, Turchet F, et al. Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis. Updates Surg. 2021 Feb;73(1):313–9. https://doi.org/10.1007/s13304-020-00908-1

24.

Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013 Oct;31(18):1726–34. https://doi.org/10.1056/NEJMra1208943

25.

Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006 Aug;12(4):315–21. https://doi.org/10.1097/01.ccx.0000235208.77450.15

26.

De Backer D. Lactic acidosis. Intensive Care Med. 2003 May;29(5):699–702. https://doi.org/10.1007/s00134-003-1746-7

27.

Nichol AD, Egi M, Pettila V, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14(1):R25. https://doi.org/10.1186/cc8888CrossRefPubMedPubMedCentral

28.

HARRIS P, BAILEY T, BATEMAN M, et al. J Appl Physiol. 1963 Sep;18:933–6. https://doi.org/10.1152/jappl.1963.18.5.933

29.

O’Connor E, Fraser JF. The interpretation of perioperative lactate abnormalities in patients undergoing cardiac surgery. Anaesth Intensive Care. 2012 Jul;40(4):598–603. https://doi.org/10.1177/0310057X1204000404

30.

Hajjar LA, Almeida JP, Fukushima JT, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug;146(2):455–60. https://doi.org/10.1016/j.jtcvs.2013.02.003

31.

Li SH, Liu F, Zhang YT. [Initial serum lactate level as predictor of morbidity after major abdominal surgery]. Zhonghua Yi Xue Za Zhi 2008 Sep 16; 88(35): 2470–3.

32.

McIntyre A, Hulikova A, Ledaki I et al. Disrupting Hypoxia-Induced bicarbonate transport Acidifies Tumor cells and suppresses Tumor Growth. Cancer Res 2016 Jul 1; 76(13): 3744–55. https://doi.org/10.1158/0008-5472.CAN-15-1862

33.

Parks SK, Pouyssegur J. The na(+)/HCO3(-) Co-Transporter SLC4A4 plays a role in Growth and Migration of Colon and breast Cancer cells. J Cell Physiol 2015 Aug; 230 (8): 1954–63. https://doi.org/10.1002/jcp.24930

34.

Abumanhal-Masarweh H, Koren L, Zinger A et al. Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin. J Control Release 2019 Feb 28; 296: 1–13. https://doi.org/10.1016/j.jconrel.2019.01.004

35.

Okorie ON, Dellinger P. Lactate: biomarker and potential therapeutic target. Crit Care Clin. 2011 Apr;27(2):299–326. https://doi.org/10.1016/j.ccc.2010.12.013

36.

Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care 2012 Jun; 18(3): 267–72. https://doi.org/10.1097/MCC.0b013e3283532b8a

37.

Ling J, Chang Y, Yuan Z et al. Designing Lactate dehydrogenase-mimicking SnSe nanosheets to reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. ACS Appl Mater Interfaces 2022 Jun 22; 14(24): 27651–65. https://doi.org/10.1021/acsami.2c05533

38.

Yang L, Tan P, Sun H et al. Integrative dissection of Novel Lactate metabolism-related signature in the Tumor Immune Microenvironment and Prognostic Prediction in breast Cancer. Front Oncol 2022 Apr 27; 12: 874731. https://doi.org/10.3389/fonc.2022.874731

39.

Jin M, Cao W, Chen B et al. Tumor-derived Lactate creates a favorable niche for Tumor via supplying Energy source for Tumor and modulating the Tumor Microenvironment. Front Cell Dev Biol 2022 May 13; 10: 808859. https://doi.org/10.3389/fcell.2022.808859

40.

41.

ten Hagen TL, Seynhaeve AL, van Tiel ST, et al. Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats. Int J Cancer. 2002 Jan;1(1):115–20. https://doi.org/10.1002/ijc.1578

42.

Gu J, Zhou J, Chen Q et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep 2022 Jun 21; 39(12): 110986. https://doi.org/10.1016/j.celrep.2022.110986

Titel: Effects of preoperative bicarbonate and lactate levels on short-term outcomes and prognosis in elderly patients with colorectal cancer
verfasst von: Xiao-Yu Liu
Zi-Wei Li
Bin Zhang
Fei Liu
Wei Zhang
Dong Peng
Publikationsdatum: 01.12.2023
Verlag: BioMed Central
Erschienen in: BMC Surgery / Ausgabe 1/2023
Elektronische ISSN: 1471-2482
DOI: https://doi.org/10.1186/s12893-023-02039-x

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Supplementary Information

Publisher’s Note

Introduction

Methods

Patients

Inclusion and exclusion criteria

Clinical data

Follow-up data

Definitions

Statistical analysis

Results

Patient

Comparison between the higher group and the lower group

Univariate and multivariate analysis

Complications between the higher group and the lower group

Discussion

Acknowledgements

Declarations

Ethics approval and informed consent

Consent for publication

Competing interests

Publisher’s Note

Electronic supplementary material

Weitere Artikel der Ausgabe 1/2023

Morbidity and oncological outcomes after intersphincteric resection of the rectum for low-lying rectal cancer: experience of a single center in a lower-middle-income country

Testicular salvageability and its predictors among patients with testicular torsion in a resource limited setting: a multicentre longitudinal study

Assessing the role of anastomotic level in low anterior resection (LAR) surgery among rectal cancer patients in the development of LAR syndrome: a systematic review study

Effect of the number of negative lymph nodes removed on the survival and recurrence rate after gastrectomy in patients with gastric cancer: a multicenter retrospective cohort study

The value of preoperative neutrophil/lymphocyte ratio in predicting the severity of cholecystolithiasis with cholecystitis in elderly patients

The application of a novel hydrodynamic cavitation device to debride intra-articular monosodium urate crystals

Update Chirurgie